Manulife (Manufacturers Life Insurance)
STRO icon

Manulife (Manufacturers Life Insurance)’s Sutro Biopharma STRO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,099
Closed -$20.2K – 3005
2025
Q1 		$20.2K Buy
3,099
+11
+0.4% +$173 ﹤0.01% 2886
2024
Q4 		$56.8K Sell
3,088
-100
-3% -$3.05K ﹤0.01% 2924
2024
Q3 		$110K Sell
3,188
-106
-3% -$4.16K ﹤0.01% 2846
2024
Q2 		$96.5K Buy
3,294
+708
+27% +$28K ﹤0.01% 2832
2024
Q1 		$146K Buy
2,586
+11
+0.4% +$486 ﹤0.01% 2687
2023
Q4 		$110K Hold
2,575
– – ﹤0.01% 2787
2023
Q3 		$89.3K Hold
2,575
– – ﹤0.01% 2842
2023
Q2 		$120K Buy
2,575
+508
+25% +$25.3K ﹤0.01% 2782
2023
Q1 		$95.5K Hold
2,067
– – ﹤0.01% 2754
2022
Q4 		$167K Buy
2,067
+187
+10% +$13K ﹤0.01% 2640
2022
Q3 		$104K Sell
1,880
-114
-6% -$6.75K ﹤0.01% 2801
2022
Q2 		$104K Buy
1,994
+117
+6% +$6.54K ﹤0.01% 2893
2022
Q1 		$154K Sell
1,877
-410
-18% -$39K ﹤0.01% 2856
2021
Q4 		$340 Sell
2,287
-13
-0.6% -$2.33K ﹤0.01% 2523
2021
Q3 		$435K Sell
2,300
-189
-8% -$35.9K ﹤0.01% 2402
2021
Q2 		$463K Buy
2,489
+606
+32% +$119K ﹤0.01% 2494
2021
Q1 		$429K Buy
1,883
+160
+9% +$38K ﹤0.01% 2388
2020
Q4 		$374K Buy
1,723
+246
+17% +$40.7K ﹤0.01% 2387
2020
Q3 		$148K Buy
1,477
+295
+25% +$27.9K ﹤0.01% 2683
2020
Q2 		$93K Buy
+1,182
New +$113K ﹤0.01% 2773

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s STRO Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 3,099 shares — an estimated $20.2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in STRO in Q2 2020 and held it in 20 quarters. The position peaked at $463K in Q2 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 3,099 Sutro Biopharma shares in Q2 2025, an estimated $20.2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Sutro Biopharma in Q2 2020 and held it in 20 quarters.
  • Manulife (Manufacturers Life Insurance)'s Sutro Biopharma position peaked at $463K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.